SLC43A1 and colorectal carcinoma: Given the contribution of active transporters to oxaliplatin accumulation in cells, it is perhaps not surprising that our genome-wide CRISPR screens identified a new transporter in CRC cells as shown by a dramatic alteration in sgRNAs directed towards the neutral amino acid transporter LAT3.